» Articles » PMID: 2789507

Quantitation and Localization of Apolipoproteins [a] and B in Coronary Artery Bypass Vein Grafts Resected at Re-operation

Overview
Date 1989 Sep 1
PMID 2789507
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Lp[a] is a lipoprotein whose plasma concentration is highly correlated with cardiovascular disease. Its protein moiety, apoLp[a], consists of two large polypeptides, apo[a] and apo B. The possible contribution of Lp[a] to atherosclerosis in saphenous vein aortocoronary bypass grafts was studied in a population of patients undergoing coronary re-bypass surgery. The vein graft tissue levels of apoLp[a] were compared with graft duration, gross and light microscopic pathology, as well as plasma levels of apoLp[a]. The localization pattern of apo[a] and apo B in vein graft tissue was determined. In addition, the plasma levels of cholesterol, triglycerides, apoproteins (apo) A-I, A-II, and E were measured. In a representative subpopulation of 17 patients with a mean age of 63 years from whom grafts with a mean duration of 112 months were resected, the mean total plasma cholesterol level was 221 mg/dl, the mean high density lipoprotein cholesterol level was 31 mg/dl, and the mean plasma triglyceride level was 228 mg/dl. In normal saphenous veins, the level of apoLp[a] was below measurable limits (less than 2 ng/mg), and the level of apo B was very low (3.3 ng/mg). In resected grafts, the mean tissue level of apoLp[a] was 32 ng/mg, and that of apo B was 70 ng/mg, demonstrating the net accumulation of these apoproteins in veins from the time of their grafting into the arterial bed. The apoLp[a]/apo B ratio was determined in 77 tissue segments from 59 grafts (28 patients) and was found to be 0.313. This tissue ratio was significantly higher (p = 0.02) than the plasma apoLp[a]/apo B ratio from these patients, which was 0.132. Immunostaining showed co-localization of apo[a] and apo B in the neointima of grafts. The most abundant pathologic features observed in resected grafts were proliferated intima (43/52), thrombus (28/52), and atherosclerotic core regions (21/52). The level of tissue apo B correlated well with the abundance of core regions (r = 0.501), whereas the level of tissue apoLp[a] did not correlate as well with this feature (r = 0.233). Although apo[a] and apo B are almost absent from normal saphenous vein, these apoproteins (and presumably the lipoproteins Lp[a] and low density lipoprotein) accumulate in bypass vein grafts. The data support the view that these lipoproteins play a significant role in vein graft atherosclerosis.

Citing Articles

Association of Lipoprotein-Associated Phospholipase A2 and Lipoprotein(a) With the Risk of Recurrence Stroke in Patients With Acute Ischemic Stroke.

Feng Y, Zhang S, Li H, Li H, Dong R, Zhu S J Clin Lab Anal. 2024; 38(24):e25120.

PMID: 39625858 PMC: 11659748. DOI: 10.1002/jcla.25120.


Evidence Accumulates: Patients with Ascending Aneurysms Are Strongly Protected from Atherosclerotic Disease.

Waldron C, Zafar M, Ziganshin B, Weininger G, Grewal N, Elefteriades J Int J Mol Sci. 2023; 24(21).

PMID: 37958625 PMC: 10650782. DOI: 10.3390/ijms242115640.


Oxidized phospholipids in cardiovascular disease.

Tsimikas S, Witztum J Nat Rev Cardiol. 2023; 21(3):170-191.

PMID: 37848630 DOI: 10.1038/s41569-023-00937-4.


Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.

Lampsas S, Xenou M, Oikonomou E, Pantelidis P, Lysandrou A, Sarantos S Molecules. 2023; 28(3).

PMID: 36770634 PMC: 9918959. DOI: 10.3390/molecules28030969.


Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction.

Enas E, Varkey B, Dharmarajan T, Pare G, Bahl V Indian Heart J. 2019; 71(2):99-112.

PMID: 31280836 PMC: 6620428. DOI: 10.1016/j.ihj.2019.03.004.